Why North American medical cannabis can’t compete globally
The United States and Canada started a movement that began as medical cannabis and quickly exploded into adult-use cannabis markets. However, the North American operators failed to properly regulate the processes from growing to manufacturing to compete in a global pharmaceutical-level market. Europe has taken the lead as the heavy-weight producer of truly medical-grade pharmaceutical cannabis flowers and products. Notably, many operators in the U.S. and Canada claim to produce …
Why North American medical cannabis can’t compete globally







![Finding peace and reclaiming humanity within a broken health care system [PODCAST]](https://kevinmd.com/wp-content/uploads/058307ba-bb36-43f1-9e3a-6e3100f183b5-190x100.jpeg)


![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)





